Incorporating Objective Behavioral and Biological Measures in a Large-Scale Decentralized Mobile Health Trial for Depression: Randomized Controlled Trial
JMIR Mental Health · 2026-10-09 · 13 · e92589-e92589
DOI: 10.2196/92589 ↗At a glance
Randomisierte kontrollierte Studie in JMIR Mental Health, published online on 2026-10-09. Written by Wendy S-Y Lau and 31 co-authors. Institution: Center for Healthy Minds, University of Wisconsin-Madison, Madison, WI, United States. Major MEDLINE topics: Depression, Mobile Applications. 59 references. The full text is freely available in PubMed Central. Funded by: NIMH NIH HHS, NCCIH NIH HHS, NLM NIH HHS.
Topics: Depression
Abstract (original language)
Background
Decentralized (ie, fully remote) clinical trials (DCTs) offer a scalable and ecologically valid approach to evaluating digital mental health interventions (DMHIs). Yet, incorporating objective measures of well-being within DCTs poses novel methodological and feasibility challenges that can limit the rigor and precision of data collection in the field.
Objective
We recently conducted the Behavior, Biology, and Well-being (BeWell) Study, a large-scale, 3-arm randomized DCT evaluating the Healthy Minds Program app (Humin)—a self-guided DMHI that includes didactic well-being information and meditation components. The current paper’s objective is to describe the methodological approach to collecting and processing a multimodal battery of psychological (questionnaires and structured clinical interview), biological (blood and stool assays), and behavioral (stimulus-elicited affect [SEA] task, video log, and Mnemonic Similarity Task [MST]) measures, longitudinally across baseline, the 4-week intervention period, and 17-week follow-up. Secondarily, we evaluate its feasibility.
Methods
The BeWell Study methodology is described. Descriptive statistics characterized recruitment and retention, as well as data completion and data quality. Binary logistic regressions evaluated whether recruitment sources, demographics, and depression severity predicted measure completion and data quality.
Results
From June 1, 2022, through July 15, 2024, 52,052 individuals started the screening questionnaire. Of these, 2.22% (n=1156 participants; mean age 38.69, SD 12.14 years; women=75.50%; non-Hispanic White=68.88%) completed the screener, met eligibility criteria (including elevated depressive symptoms [Patient Health Questionnaire-9 [PHQ-9] score≥5]), completed baseline measures, were enrolled, and were randomized. Participants were recruited from Craigslist (694/1154, 60.14%), a US-based advertisement website, and university email messages (107/1154, 9.27%); participants were enrolled from every US state. Across the study, 84% (971/1156) of participants were retained (completed ≥1 measure at 17-week follow-up). Across time points, ≥81.40% (941/1156) of participants completed questionnaires and ≥75.17% (869/1156) completed biological samples. Of those completing questionnaires, ≥84.14% (796/946) completed SEA and video log tasks and ≥91.75% (868/946) completed the MST. Of completed assessments, high-quality or analyzable data rates across all time points were ≥97.89% (926/946) for questionnaires, ≥90.20% (773/857) for SEA, ≥84.60% (725/857) for video logs, ≥94.20% (1056/1121) for the MST, ≥98.84% (849/859) for dried blood spots, and ≥99.43% () for microbiome samples. Greater depressive symptoms at screening, but not age, predicted completion of baseline measures (odds ratios 0.96‐0.99; P
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Center for Healthy Minds, University of Wisconsin-Madison, Madison, WI, United States.
- Department of Counseling Psychology, University of Wisconsin-Madison, 335 Education Building, 1000 Bascom Mall, Madison, WI, 53703, United States, 1 (608) 265-8986.
- Wisconsin Institute of Discovery, University of Wisconsin-Madison, Madison, WI, United States.
- MIT Media Lab, Massachusetts Institute of Technology, Cambridge, MA, United States.
- Humin, Madison, WI, United States.
- Department of Statistics, University of Wisconsin-Madison, Madison, WI, United States.
Funding
- NIMH NIH HHS
- NCCIH NIH HHS
- NLM NIH HHS
Cite
APA
Lau, W. S., Swords, C. M., Thairu, M. W., Hidalgo, N., Tatar, R., Rahrig, H., Wilson-Mendenhall, C. D., Grupe, D. W., Goldman, R. I., Vack, N. J., Ferguson, C., Valdivia, G., Sankaran, K., Frye, C., Dahl, C. J., Lewis, R., Higgins, E. T., Garza, M., Jiwani, Z., …, & Goldberg, S. B. (2026). Incorporating Objective Behavioral and Biological Measures in a Large-Scale Decentralized Mobile Health Trial for Depression: Randomized Controlled Trial. JMIR Mental Health, 13, e92589-e92589. https://doi.org/10.2196/92589
Vancouver
Lau WS, Swords CM, Thairu MW, Hidalgo N, Tatar R, Rahrig H, et al. Incorporating Objective Behavioral and Biological Measures in a Large-Scale Decentralized Mobile Health Trial for Depression: Randomized Controlled Trial. JMIR Mental Health. 2026;13:e92589-e92589. doi:10.2196/92589
BibTeX
@article{Lau2026,
author = {Lau, Wendy S-Y and Swords, Caroline M and Thairu, Margaret W and Hidalgo, Nelson and Tatar, Raquel and Rahrig, Hadley and Wilson-Mendenhall, Christine D and Grupe, Daniel W and Goldman, Robin I and Vack, Nathaniel J and Ferguson, Craig and Valdivia, Gabriela and Sankaran, Kris and Frye, Corrina and Dahl, Cortland J and Lewis, Robert and Higgins, Estelle T and Garza, Mason and Jiwani, Zishan and Hirshberg, Matthew J and Bernstein, Amit and Converse, Ellen and Dimidjian, Sona and Ward, Earlise C and Miller, Gregory E and McDade, Thomas W and Picard, Rosalind W and Handelsman, Jo and Rosenkranz, Melissa A and Abercrombie, Heather C and Davidson, Richard J and Goldberg, Simon B},
title = {Incorporating Objective Behavioral and Biological Measures in a Large-Scale Decentralized Mobile Health Trial for Depression: Randomized Controlled Trial},
journal = {JMIR Mental Health},
year = {2026},
volume = {13},
pages = {e92589--e92589},
doi = {10.2196/92589}
}
EUVIMED